 Geneva, Switzerland and Boston, MA 2 November, 2020 ObsEva SA NASDAQ: OBSV SIX: OBSN, a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve womens reproductive health, today announced an oral communication and a live symposium at SEUD Online Week 2020 to take place November 3 6. 